The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Will Be The Estimated Market Size Of The Chemiluminescence Immunoassay Market By 2030?
The chemiluminescence immunoassay market size has experienced robust expansion in recent years. It is projected to expand from $14.85 billion in 2025 to $16.15 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. The historical increase can be ascribed to the increasing prevalence of infectious and chronic diseases, the expansion of centralized diagnostic laboratories, the escalating demand for accurate biomarker detection, the broader adoption of automated laboratory systems, and the growing application of immunoassays in clinical diagnostics.
The chemiluminescence immunoassay market is anticipated to experience substantial expansion in the coming years, with projections indicating it will reach $22.35 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.5%. This growth during the forecast period is primarily attributed to a heightened demand for prompt disease identification, the increasing embrace of personalized medicine diagnostics, the proliferation of decentralized testing models, the expanding integration of AI-assisted diagnostic interpretation, and greater investment in advanced clinical laboratory infrastructure. Furthermore, significant trends expected over this period include a wider uptake of fully automated immunoassay analyzers, an escalating requirement for high-sensitivity diagnostic kits, the broadening application of multiplex testing capabilities, the spread of rapid and point-of-care CLIA systems, and a sharpened emphasis on standardized reagent performance.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27252&type=smp
Which Drivers Are Advancing The Chemiluminescence Immunoassay Market Growth?
The increasing occurrence of infectious diseases is projected to drive the expansion of the chemiluminescence immunoassay market in the future. Infectious diseases are defined as illnesses resulting from detrimental microorganisms, including bacteria, viruses, fungi, or parasites, capable of spreading between individuals directly or indirectly. The rise in antimicrobial resistance, which makes standard treatments ineffective and permits infections to linger and spread, is contributing to the growing prevalence of these diseases. Chemiluminescence immunoassays support the diagnosis of infectious diseases through highly sensitive and specific detection of biomarkers, facilitating the prompt and precise identification of pathogens. They minimize diagnostic wait times by offering quick and dependable outcomes, thus enhancing patient care and therapeutic results. For instance, in February 2024, the UK Health Security Agency, a UK-based government agency, reported that tuberculosis (a contagious bacterial infection primarily affecting the lungs) cases in England climbed to 4,850 in 2023, marking an increase of 10.7% from 4,380 cases in 2022. Consequently, the rising prevalence of infectious diseases is fueling the growth of the chemiluminescence immunoassay market.
What Are The Major Segment Categories Within The Chemiluminescence Immunoassay Market?
The chemiluminescence immunoassay market covered in this report is segmented –
1) By Product Type: Analyzers, Kits, Reagents
2) By Sample Type: Blood, Saliva, Urine, Other Samples
3) By Technology: Chemiluminescence Enzyme Technology (CLEIA), Electrochemiluminescence Immunoassay (ECLI), Microparticle Chemiluminescence Immunoassay
4) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease, Other Applications
5) By End-User: Hospitals, Pharmaceutical And Biotechnology Companies, Clinical Laboratories, Other End-Users
Subsegments:
1) By Analyzers: Fully Automated Analyzers, Semi Automated Analyzers, Portable Analyzers
2) By Kits: Detection Kits, Quantitative Kits, Qualitative Kits, Multiparameter Kits
3) By Reagents: Luminol Reagents, Isoluminol Reagents, Acridinium Ester Reagents, Other Reagents
What Trends Are Shaping The Chemiluminescence Immunoassay Market Structure?
Major companies operating in the chemiluminescence immunoassay market are prioritizing the development of advanced products, such as sophisticated chemiluminescence immunoassay analyzers, to improve test accuracy, increase throughput, and deliver faster diagnostic results for a broad spectrum of clinical applications. Chemiluminescence immunoassay analyzers are automated instruments designed to detect and quantify light emitted during chemical reactions, enabling accurate identification of specific biomarkers in diagnostic tests. For instance, in July 2023, Fapon Biotech Inc., a biotechnology company based in China, introduced the Shine i8000/9000, a chemiluminescence immunoassay analyzer. This system is tailored for medium to large laboratories, providing rapid preliminary results within 10 minutes and ensuring high precision, all within a compact, stable, and user-friendly design. Its notable features include a 360-degree large-span display, a one-touch bulk loading system for reaction cups, a dual-tube backup substrate system, and automated reaction cup disposal to minimize contamination. The fully automated workflow lessens manual intervention, while advanced algorithms improve result consistency, making it well-suited for high-volume diagnostic settings.
Which Key Players Are Active In The Chemiluminescence Immunoassay Market?
Major companies operating in the chemiluminescence immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Revvity Inc., DiaSorin S.p.A., Tecan Group Ltd., Euroimmun AG, Randox Laboratories Ltd., Autobio Diagnostics Co. Ltd., Wondfo Biotech Co. Ltd., Fujirebio Diagnostics Inc., Trivitron Healthcare Pvt. Ltd., Getein Biotech Inc., Fapon Biotech Inc., Diazyme Laboratories Inc.
Access The Complete Chemiluminescence Immunoassay Market Report:
https://www.thebusinessresearchcompany.com/report/chemiluminescence-immunoassay-global-market-report
Which Regional Market Leads The Chemiluminescence Immunoassay Market?
North America was the largest region in the chemiluminescence immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemiluminescence immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Chemiluminescence Immunoassay Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=27252&type=smp
Browse Through More Reports Similar to the Global Chemiluminescence Immunoassay Market 2026, By The Business Research Company
Healthcare Chatbots Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/healthcare-chatbots-global-market-report
Chatbot Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/chatbot-global-market-report
Artificial Intelligence Ai Chatbot Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model